haemato-oncology Archives -

Despite the effects of countries’ lockdown policies, a plethora of clinical trial readouts continue to emerge providing several

Clinical decision-making insights for haem/oncs

https://pharmaphorum.com/oncology/clinical-decision-making-insights-haem-oncs/

Antibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents. Although just

When science and biology combine – the outlook for ADCs in cancer drug development

https://pharmaphorum.com/partner-content-oncology/science-biology-combine-outlook-adcs-cancer-drug-development/

FDA gives green light after 7-year absence

FDA reapproves Pfizer’s Mylotarg leukaemia drug

https://pharmaphorum.com/news/fda-reapproves-pfizers-mylotarg-leukaemia-drug/

haemato-oncology